Institutional Ownership Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS). We have compiled data on the 169 institutions that hold shares in the stock, with a total of 35.4 Million shares, which have been reported (via 13F filing form) to have a value of $610 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
5,389,264
shares
|
$93 Million
8.01% of portfolio
|
Q2 2025
Added 262.56%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
2,718,777
shares
|
$46.9 Million
0.0% of portfolio
|
Q3 2025
Added 3.31%
|
|
|
Madison Avenue Partners, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,708,218
shares
|
$46.7 Million
3.92% of portfolio
|
Q3 2025
Added 0.62%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,513,244
shares
|
$43.4 Million
0.0% of portfolio
|
Q2 2024
Added 16.03%
|
|
|
Western Standard LLC
Los Angeles, CA |
Nov 12, 2025 Q3 2025 |
2,189,882
shares
|
$37.8 Million
10.27% of portfolio
|
Q3 2025
Added 42.67%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
1,418,984
shares
|
$24.5 Million
1.02% of portfolio
|
Q2 2025
Added 29.0%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2025 Q3 2025 |
1,331,425
shares
|
$23 Million
0.01% of portfolio
|
Q3 2025
Added 2.62%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,325,483
shares
|
$22.9 Million
0.0% of portfolio
|
Q3 2025
Added 50.02%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,302,978
shares
|
$22.5 Million
0.0% of portfolio
|
Q3 2025
Reduced 5.87%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Nov 14, 2025 Q3 2025 |
1,233,189
shares
|
$21.3 Million
0.79% of portfolio
|
Q3 2025
Reduced 23.91%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
1,018,734
shares
|
$17.6 Million
0.55% of portfolio
|
Q3 2024
Reduced 19.7%
|
|
|
Alkeon Capital Management LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
850,511
shares
|
$14.7 Million
0.02% of portfolio
|
Q1 2025
Reduced 22.75%
|
|
|
Logos Global Management LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
850,000
shares
|
$14.7 Million
1.56% of portfolio
|
Q3 2025
Reduced 57.5%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
837,363
shares
|
$14.5 Million
0.0% of portfolio
|
Q3 2025
Added 0.97%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 17, 2025 Q3 2025 |
607,089
shares
|
$10.5 Million
0.04% of portfolio
|
Q3 2025
Added 15.78%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
552,506
shares
|
$9.54 Million
0.96% of portfolio
|
Q1 2024
New holding
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 03, 2025 Q3 2025 |
514,160
shares
|
$8.87 Million
0.02% of portfolio
|
Q3 2025
Reduced 21.39%
|
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
407,633
shares
|
$7.04 Million
6.41% of portfolio
|
Q3 2023
Added 1.37%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
395,103
shares
|
$6.82 Million
0.0% of portfolio
|
Q3 2025
Reduced 55.04%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 13, 2025 Q3 2025 |
335,154
shares
|
$5.78 Million
0.02% of portfolio
|
Q3 2025
Added 26.14%
|
|
|
Pdt Partners, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
332,815
shares
|
$5.74 Million
0.36% of portfolio
|
Q2 2025
Added 20.56%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
332,758
shares
|
$5.74 Million
0.0% of portfolio
|
Q3 2025
Added 21.83%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
303,122
shares
|
$5.23 Million
0.01% of portfolio
|
Q3 2025
Added 683.73%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
292,006
shares
|
$5.04 Million
0.0% of portfolio
|
Q3 2025
Added 3.04%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Nov 13, 2025 Q3 2025 |
258,754
shares
|
$4.47 Million
0.0% of portfolio
|
Q3 2025
Added 300.67%
|
|